Precipio Diagnostics
Latest round
- Series B
Last raised
- Oct 2013
Total raised
- $1.8M
Investors
- 4
About Precipio Diagnostics
Precipio Diagnostics, LLC, founded in 2011 in New Haven, US, develops diagnostic products for blood cancers.Precipio Diagnostics focuses on proprietary hematopathology diagnostic products that enhance the accuracy and efficiency of diagnosing blood cancers, including myeloproliferative neoplasms, chronic myeloid leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and myelodysplastic syndromes.Precipio generates revenue through the sale of diagnostic products and services to clinical laboratories and healthcare institutions. Their flagship products include Bloodhound™ BCR-ABL1 and Bloodhound™ MPN panels, which are directly sold to labs for diagnostic testing.Looking ahead, Precipio Diagnostics aims to expand its product offerings and enhance its market reach.8 mn from October 2013 will be utilized to support the development of new diagnostic solutions. The company is also exploring opportunities to enter new geographic markets, with specific plans for expansion in Europe and Asia by 2025.
Who invested in Precipio Diagnostics
4 investors across 1 round
See all investors in Precipio Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 17, 2013
Amount
$1.8M
Investors
Questions about Precipio Diagnostics
Who invested in Precipio Diagnostics?
Precipio Diagnostics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Precipio Diagnostics raised?
Precipio Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Precipio Diagnostics last raise money?
Precipio Diagnostics's most recent round on record is a Series B, in Oct 2013.
What does Precipio Diagnostics do?
Precipio Diagnostics, LLC, founded in 2011 in New Haven, US, develops diagnostic products for blood cancers.
Where is Precipio Diagnostics headquartered?
Precipio Diagnostics is headquartered in New Haven, US.
Which VCs invest in companies like Precipio Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Precipio Diagnostics's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Precipio Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.